Additionally, serum MSTN levels were associated with muscular atrophy of the lower extremities, which suggests that MSTN may be an important factor in maintaining the mass and strength of skeletal muscles in patients with heart failure [59]. This evidence concerns the gene MSTN and muscular atrophy.